MCID: VST003
MIFTS: 28

Vestibular Nystagmus malady

Category: Eye diseases

Aliases & Classifications for Vestibular Nystagmus

About this section

Aliases & Descriptions for Vestibular Nystagmus:

Name: Vestibular Nystagmus 10 12
 
Nystagmus Associated with Disorder of the Vestibular System 10 65

Classifications:



External Ids:

Disease Ontology10 DOID:14070
SNOMED-CT59 46888001
ICD9CM29 379.54
UMLS65 C0155379

Summaries for Vestibular Nystagmus

About this section
MalaCards based summary: Vestibular Nystagmus, also known as nystagmus associated with disorder of the vestibular system, is related to obesity and leukocoria. An important gene associated with Vestibular Nystagmus is DTNA (Dystrobrevin Alpha). Affiliated tissues include testes, eye and breast, and related mouse phenotypes are craniofacial and nervous system.

Related Diseases for Vestibular Nystagmus

About this section

Graphical network of the top 20 diseases related to Vestibular Nystagmus:



Diseases related to vestibular nystagmus

Symptoms for Vestibular Nystagmus

About this section

Drugs & Therapeutics for Vestibular Nystagmus

About this section

Drugs for Vestibular Nystagmus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 10)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Anti-Bacterial AgentsPhase 49140
2GentamicinsPhase 4123
3Anti-Infective AgentsPhase 417220
4
PrednisoneapprovedPhase 2126753-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
5Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 29988
6HormonesPhase 211748
7Antineoplastic Agents, HormonalPhase 24256
8Anti-Inflammatory AgentsPhase 28478
9glucocorticoidsPhase 23896
10Hormone AntagonistsPhase 210002

Interventional clinical trials:

(show all 18)
idNameStatusNCT IDPhase
1Gentamicin Treatment Prior to Schwannoma Surgery - No Residual FunctionRecruitingNCT02415257Phase 4
2Gentamicin Treatment Prior to Schwannoma Surgery - Residual FunctionRecruitingNCT02379754Phase 4
3Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional VertigoCompletedNCT01366430Phase 3
4Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional VertigoCompletedNCT00810641Phase 3
5Prednisone Treatment for Vestibular NeuronitisCompletedNCT00271791Phase 2
6Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional VertigoCompletedNCT02046980Phase 2
7Effect of Vestibular Rehabilitation - a Randomized Controlled TrialCompletedNCT00702832
8Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo (VEMP in BPPV)CompletedNCT01004913
9Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and MigraineCompletedNCT02615314
10Accuracy of a Diagnostic Algorithm for the Differential Diagnosis of Vertigo in the ED: the STANDING.CompletedNCT02782962
11Gaze Holding in Cerebellar PatientsRecruitingNCT02185313
12BPPV Treatment in Biaxial Rotational ChairRecruitingNCT01905800
13Treatment of Posterior Canal Type of Benign Paroxysmal Positional VertigoRecruitingNCT01822002
14BPPV With CRP: Single Versus Multiple CyclesRecruitingNCT02701218
15Functional Link Between Hippocampal and Vestibular Systems: a Pilot Study in Epilepsy SurgeryActive, not recruitingNCT01285921
16Helpfulness of the Vibration Test Performed in Room Light on Clients With Inner Ear ProblemsEnrolling by invitationNCT02626052
17Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar DisorderNot yet recruitingNCT02778256
18Prospective Assessment of Peripheral-vestibular Function After Skull Base SurgeryNot yet recruitingNCT02773277

Search NIH Clinical Center for Vestibular Nystagmus

Genetic Tests for Vestibular Nystagmus

About this section

Anatomical Context for Vestibular Nystagmus

About this section

MalaCards organs/tissues related to Vestibular Nystagmus:

33
Testes, Eye, Breast, Bone, Colon, Monocytes, Lung

Animal Models for Vestibular Nystagmus or affiliated genes

About this section

MGI Mouse Phenotypes related to Vestibular Nystagmus:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053828.9CYCS, FOXD3, MED12, NF2, TWIST1
2MP:00036318.0CYCS, DTNA, FOXD3, GBA, MED12, MYRF
3MP:00053867.6CYCS, DEGS1, DTNA, GBA, HTR2A, MYRF
4MP:00053907.4CYCS, DEGS1, DTNA, FOXD3, GBA, HTR2A
5MP:00053786.9CYCS, DEGS1, DPT, DTNA, FOXD3, GBA
6MP:00107686.6CYCS, DEGS1, DTNA, FOXD3, GBA, MED12

Publications for Vestibular Nystagmus

About this section

Articles related to Vestibular Nystagmus:

(show top 50)    (show all 152)
idTitleAuthorsYear
1
Thymic hyperplasia and chylothorax. (25976649)
2015
2
Critical role of IL-33 receptor ST2 in experimental cerebral malaria development. (25682948)
2015
3
Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study. (24475310)
2014
4
Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease. (25277751)
2014
5
Association of depressive symptoms, trait anxiety, and perceived stress with subclinical atherosclerosis: Results from the Chicago Healthy Aging Study (CHAS). (24434161)
2014
6
Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RNase 7, human beta-defensin-2 and -3 in healthy human skin. (23614747)
2013
7
Comparison between Parametric and Semi-parametric Cox Models in Modeling Transition Rates of a Multi-state Model: Application in Patients with Gastric Cancer Undergoing Surgery at the Iran Cancer Institute. (24377600)
2013
8
Neonatal burns in Lagos, South-Western Nigeria: Epidemiology and outcome of management. (22995424)
2013
9
Anti-U-like as an alloantibody in S-s-U- and S-s-U+(var) black people. (21880045)
2012
10
Cardiopulmonary assessment in primary ciliary dyskinesia. (22121832)
2012
11
Rickettsia monacensis as cause of Mediterranean spotted fever-like illness, Italy. (22469314)
2012
12
Cyclic changes in the level of the innate immune molecule, surfactant protein-a, and cytokines in vaginal fluid. (22672628)
2012
13
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. (21215925)
2011
14
Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. (21829673)
2011
15
A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. (20085812)
2010
16
The role of insulin like growth factor (IGF)-1 and IGF-binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children. (19381505)
2009
17
Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. (19647104)
2009
18
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. (18676826)
2008
19
MoV electron paramagnetic resonance of sulfite oxidase revisited: the low-pH chloride signal. (18271529)
2008
20
Myths and facts... About shaken baby syndrome. (18418161)
2008
21
Pathology of mucopolysaccharidosis IIIA in Huntaway dogs. (17846229)
2007
22
That balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries is another powerful argument in favor of therapeutic closure of every patent foramen ovale. (16828611)
2006
23
Synchronous vulvar intraepithelial neoplasia (VIN) of warty type and cervical intraepithelial neoplasia (CIN): case report. (17183865)
2006
24
Neurofibrosarcoma - complicating neurofibromatosis-I: case report and review of relevant literature. (16160727)
2005
25
Localization of myosin phosphatase target subunit and its mutants. (15999227)
2005
26
The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes. (15713351)
2005
27
Characterization of the rat INSL3 receptor. (15956681)
2005
28
BCL-6: rearrangement and mutation in lymphoma. (15998973)
2005
29
Pedunculated aggressive angiomyxoma arising from the vaginal suburethral area: case report and review of literature. (16285583)
2005
30
Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion. (15172403)
2004
31
IGF-I in mammary tumorigenesis and diabetes. (15517902)
2004
32
A pilot study of D-cycloserine in subjects with autistic disorder. (15514414)
2004
33
Atrial septal aneurysm with right-to-left interatrial shunting. (12638676)
2003
34
Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation. (12392815)
2002
35
Genomic structure and mapping of human orphan receptor LXR alpha: upregulation of LXRa mRNA during monocyte to macrophage differentiation. (11480455)
2000
36
nm23 Expression in choroidal melanoma. (11015036)
2000
37
Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin. (10612483)
1999
38
Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions. (10677119)
1999
39
Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. (9554873)
1998
40
Use of tolfenamic acid in febrile children with and without glucose-6-phosphate dehydrogenase deficiency. (9088998)
1997
41
Hepatotropic viruses and autoimmunity 1997. (9097272)
1997
42
Rhabdomyolysis and group B streptococcus meningitis in an elderly patient with hairy cell leukemia. (11864218)
1997
43
Expression, purification, and co-crystallization of IRF-I bound to the interferon-beta element PRDI. (9315689)
1997
44
Thyroxine exacerbates absence seizures in juvenile myoclonic epilepsy. (8757055)
1996
45
General neuropsychological characteristics of frontal lobe epilepsy. (8964278)
1996
46
Inhibition of c-Jun DNA binding by mitogen-activated protein kinase. (1421569)
1992
47
Platelet-derived growth factor: purification and partial characterization. (291037)
1979
48
Pelvic lipomatosis presenting as acute ureteric obstruction. (990689)
1976
49
Aniseikonia. I. The influence of the magnification percentage of afocal meridional lenses on the magnitude of the stereoscopic depth effect. (4412029)
1974
50
Two Cases of Acute Suppurative Frontal Sinusitis, due to Bathing. (19977794)
1914

Variations for Vestibular Nystagmus

About this section

Expression for genes affiliated with Vestibular Nystagmus

About this section
Search GEO for disease gene expression data for Vestibular Nystagmus.

Pathways for genes affiliated with Vestibular Nystagmus

About this section

GO Terms for genes affiliated with Vestibular Nystagmus

About this section

Sources for Vestibular Nystagmus

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet